DK156652C - Analogifremgangsmaade til fremstilling af pyridinyloxypropanolamin-derivater eller farmaceutiske acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af pyridinyloxypropanolamin-derivater eller farmaceutiske acceptable syreadditionssalte deraf

Info

Publication number
DK156652C
DK156652C DK133282A DK133282A DK156652C DK 156652 C DK156652 C DK 156652C DK 133282 A DK133282 A DK 133282A DK 133282 A DK133282 A DK 133282A DK 156652 C DK156652 C DK 156652C
Authority
DK
Denmark
Prior art keywords
pyridinyloxypropanolamine
analogue
derivatives
preparation
acid addition
Prior art date
Application number
DK133282A
Other languages
Danish (da)
English (en)
Other versions
DK133282A (da
DK156652B (da
Inventor
Philippe Manoury
Jean Binet
Icilio Cavero
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of DK133282A publication Critical patent/DK133282A/da
Publication of DK156652B publication Critical patent/DK156652B/da
Application granted granted Critical
Publication of DK156652C publication Critical patent/DK156652C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK133282A 1981-03-25 1982-03-24 Analogifremgangsmaade til fremstilling af pyridinyloxypropanolamin-derivater eller farmaceutiske acceptable syreadditionssalte deraf DK156652C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8106005 1981-03-25
FR8106005A FR2502618A1 (fr) 1981-03-25 1981-03-25 Derives de pyridine, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
DK133282A DK133282A (da) 1982-09-26
DK156652B DK156652B (da) 1989-09-18
DK156652C true DK156652C (da) 1990-02-05

Family

ID=9256643

Family Applications (1)

Application Number Title Priority Date Filing Date
DK133282A DK156652C (da) 1981-03-25 1982-03-24 Analogifremgangsmaade til fremstilling af pyridinyloxypropanolamin-derivater eller farmaceutiske acceptable syreadditionssalte deraf

Country Status (20)

Country Link
US (1) US4406907A (fi)
EP (1) EP0061379B1 (fi)
JP (1) JPS57169462A (fi)
AR (1) AR231281A1 (fi)
AT (1) ATE15895T1 (fi)
AU (1) AU545747B2 (fi)
CA (1) CA1185978A (fi)
DE (1) DE3266607D1 (fi)
DK (1) DK156652C (fi)
ES (1) ES510724A0 (fi)
FI (1) FI75808C (fi)
FR (1) FR2502618A1 (fi)
GR (1) GR75930B (fi)
HU (1) HU186488B (fi)
IE (1) IE52654B1 (fi)
IL (1) IL65336A (fi)
MX (1) MX156114A (fi)
NO (1) NO159850C (fi)
NZ (1) NZ200118A (fi)
ZA (1) ZA822008B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6218598A (en) * 1997-01-30 1998-08-25 Synthelabo Alpha-azacyclomethyl benzothiophene and alpha-azacyclomethyl benzofurane derivatives, preparation and therapeutic application
FR2758820B1 (fr) * 1997-01-30 1999-02-26 Synthelabo Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique
CN113490670B (zh) 2019-08-05 2023-06-02 北京志健金瑞生物医药科技有限公司 含氮多环稠环类化合物,其药物组合物、制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
US4195090A (en) * 1973-02-20 1980-03-25 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)pyridine derivatives and pharmaceutical compositions therewith
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano

Also Published As

Publication number Publication date
DE3266607D1 (en) 1985-11-07
ES8303346A1 (es) 1983-02-01
HU186488B (en) 1985-08-28
AU8187382A (en) 1982-09-30
IL65336A (en) 1985-08-30
EP0061379B1 (fr) 1985-10-02
CA1185978A (en) 1985-04-23
IE820682L (en) 1982-09-25
US4406907A (en) 1983-09-27
NO820979L (no) 1982-09-27
DK133282A (da) 1982-09-26
NZ200118A (en) 1984-09-28
FI75808C (fi) 1988-08-08
JPS6135185B2 (fi) 1986-08-12
ES510724A0 (es) 1983-02-01
FI75808B (fi) 1988-04-29
IE52654B1 (en) 1988-01-06
FR2502618B1 (fi) 1983-12-23
FI821034L (fi) 1982-09-26
ATE15895T1 (de) 1985-10-15
NO159850C (no) 1989-02-15
AU545747B2 (en) 1985-08-01
MX156114A (es) 1988-07-12
EP0061379A1 (fr) 1982-09-29
AR231281A1 (es) 1984-10-31
ZA822008B (en) 1983-02-23
FR2502618A1 (fr) 1982-10-01
GR75930B (fi) 1984-08-02
FI821034A0 (fi) 1982-03-24
IL65336A0 (en) 1982-05-31
NO159850B (no) 1988-11-07
JPS57169462A (en) 1982-10-19
DK156652B (da) 1989-09-18

Similar Documents

Publication Publication Date Title
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK156720C (da) Analogifremgangsmaade til fremstilling af benzazepinderivater eller fysiologisk acceptable syreadditionssalte deraf
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK149308C (da) Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK152430C (da) Analogifremgangsmaade til fremstilling af heterocyclisk substituerede 4-amino-6,7-dimethoxy-2-piperazinoquinazolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK148795C (da) Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK148596C (da) Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK162842C (da) Analogifremgangsmaade til fremstilling af 1-perfluoralkyl-2-(1,2,4-triazol-1-yl)-ethanol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK154557C (da) Analogifremgangsmaade til fremstilling af 3,4-dihydro-8-((2-hydroxy-3-alkylamino)-propoxy)-2h-1-benzopyranderivater eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK321482A (da) Fremgangsmaade til fremstilling af 1-imidazolyl-2-phenyl-8-piperazinylphenoxy-octan-2-ol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK160498C (da) Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf
DK149841C (da) Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK15282A (da) Fremgangsmaade til fremstilling af (+)-enantiomere eller (+)(-)-racemiske 4a,9b-trans-hexahydro-1h-pyridoindol-derivater eller farmaceutisk acceptable syreadditionssalte deraf
DK150597C (da) Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf
DK157023C (da) Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK148281C (da) Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf
DK157135C (da) Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK148903C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed